In a new phase 3, double-blind study, researchers explored the efficacy and safety of combination therapy using subcutaneous (SC) belimumab and rituximab for the treatment of active systemic lupus ...
Gloved hand holding infusion line. Source: Getty Images Investigators report significantly improved cancer-specific and overall survival. WASHINGTON, DC—Sequential intravesical gemcitabine-docetaxel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback